文献速递心胸血管麻醉术前评估与围术期医学

心脏搭桥手术围术期静脉铁剂追踪:前瞻性单中心预试验

Perioperative Tracking of Intravenous Iron in Patients Undergoing On-Pump Cardiac Surgery: A Prospective, Single-Center Pilot Trial.
PubMed 文献 · Anesth Analg · 2023-02-17

该前瞻性单中心预试验纳入13例贫血和10例对照患者,贫血患者术前12-96小时接受500mg静脉羧麦芽糖铁(FCM),用液相色谱-电感耦合等离子体质谱法追踪围术期FCM浓度。结果显示术前<48小时给药者血清FCM水平较高,但大部分FCM仍被整合入铁储备,仅少量可能在手术出血中丢失且细胞 salvage 回收有限。

要点

  • 术前≥48小时给铁,几乎全部FCM整合入铁储备。
  • 术前<48小时给铁,多数仍整合,但少量可能术中丢失。
  • 细胞 salvage 对FCM回收有限,弃液袋中仅微量。

核心结论

  • 数据提示术前≥48小时给药时几乎全部FCM整合入铁储备。
  • 术前<48小时给药时多数FCM在手术时已整合,但少量可能因出血丢失且细胞 salvage 回收有限。

研究设计与样本

  • 前瞻性单中心预试验,纳入13例贫血和10例对照患者。
  • 贫血患者术前12-96小时接受500mg静脉FCM,用液相色谱-电感耦合等离子体质谱法区分药物FCM与血清铁。

主要发现

  • 500mg FCM中,<48小时给药者整合327.37(257.96-402.48)mg,≥48小时给药者整合493.60(487.78-496.70)mg。
  • 术后<48小时组血浆FCM浓度下降-27.1(-30至-5.9)µg/mL。
  • 细胞 salvage 弃液袋中FCM<48小时组为4.2(3.0-25.8)µg/mL,相当于总量29.0(19.0-40.7)mg,约占500mg的5.8%(1/17)。
  • 自体红细胞浓缩物中几乎无FCM(<48小时组0.1(0.0-0.43)µg/mL)。

临床怎么用

  • 贫血患者择期心脏手术前可考虑≥48小时给予静脉FCM以优化铁储备整合。
  • 若术前<48小时给铁,应知晓少量FCM可能术中丢失且细胞 salvage 回收有限。

局限性

  • 单中心预试验样本量小(贫血13例,对照10例),结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preoperative intravenous iron administration is a frequently used patient blood management procedure. If the timeframe of intravenous iron administration before surgery is short, (1) the concentration of the intravenous iron compound might still be high in patients' plasma when undergoing surgery and (2) this iron in patients' plasma is at risk to be lost due to blood loss. The aim of the current study was, therefore, to track the iron compound ferric carboxymaltose (FCM) before, during, and after cardiac surgery requiring cardiopulmonary bypass, with an emphasis on intraoperative iron losses in shed blood and potential recovery through autologous cell salvage. METHODS: Concentrations of FCM were analyzed in patients' blood using a hyphenation of liquid chromatography and inductively coupled plasma-mass spectrometry to distinguish between pharmaceutical compound FCM and serum iron. In this prospective, single-center pilot trial, 13 anemic and 10 control patients were included. Anemic patients with hemoglobin levels ≤12/13 g/dL in women and men were treated with 500 milligrams (mg) intravenous FCM 12 to 96 hours before elective on-pump cardiac surgery. Patients' blood samples were collected before surgery and at days 0, 1, 3, and 7 after surgery. One sample each was taken of the cardiopulmonary bypass, the autologous red blood cell concentrate generated by cell salvage, and the cell salvage disposal bag. RESULTS: Patients who had received FCM <48 hours before surgery had higher FCM serum levels (median [Q1-Q3], 52.9 [13.0-91.6]) compared to ≥48 hours (2.1 [0.7-5.1] µg/mL, P = .008). Of 500-mg FCM administered <48 hours, 327.37 (257.96-402.48) mg were incorporated compared to administration ≥48 hours with 493.60 (487.78-496.70) mg. After surgery, patients' plasma FCM concentration in the FCM <48 hours group was decreased (-27.1 [-30 to -5.9] µg/mL). Little FCM was found in the cell salvage disposal bag (<48 hours, 4.2 [3.0-25.8] µg/mL, equivalent to 29.0 [19.0-40.7] mg total; equivalent to 5.8% or 1/17th of the 500 mg FCM initially administered), almost none in the autologous red blood cell concentrate (<48 hours, 0.1 [0.0-0.43] µg/mL). CONCLUSIONS: The data generate the hypotheses that nearly all FCM is incorporated into iron stores with administration ≥48 hours before surgery. When FCM is given <48 hours of surgery, the majority is incorporated into iron stores by the time of surgery, although a small amount may be lost during surgical bleeding with limited recovery by cell salvage.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Olivier RMR, Macke M, Müller JC, et al. Perioperative Tracking of Intravenous Iron in Patients Undergoing On-Pump Cardiac Surgery: A Prospective, Single-Center Pilot Trial. Anesth Analg. 2023. PMID: 36811991. doi:10.1213/ANE.0000000000006372

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。